1. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week
- Author
-
PA Bob Kutys, Liang Guo, Yu Sato, Anne Cornelissen, Irene Pescetelli, Maria Romero, Masayuki Mori, Kenji Kawai, Dario Pellegrini, Giulio Guagliumi, Matteo Brivio, Rika Kawakami, Ahmed Nasr, Andrea Gianatti, Atsushi Sakamoto, Renu Virmani, and Aloke V. Finn
- Subjects
Pathology ,medicine.medical_specialty ,Myocarditis ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Biopsy ,Autopsy ,heart ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Virus ,03 medical and health sciences ,0302 clinical medicine ,cardiovascular disease ,medicine ,Humans ,030212 general & internal medicine ,Respiratory system ,JACC Review Topic of the Week ,Pathological ,Coronavirus ,medicine.diagnostic_test ,SARS-CoV-2 ,business.industry ,Myocardium ,The Present and Future ,SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2 ,STEMI, ST-segment elevation myocardial infarction ,COVID-19 ,medicine.disease ,CMR, cardiac magnetic resonance imaging ,EMB, endomyocardial biopsy ,Cardiology and Cardiovascular Medicine ,business - Abstract
To investigate whether severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)–induced myocarditis constitutes an important mechanism of cardiac injury, a review was conducted of the published data and the authors’ experience was added from autopsy examination of 16 patients dying of SARS-CoV-2 infection. Myocarditis is an uncommon pathologic diagnosis occurring in 4.5% of highly selected cases undergoing autopsy or endomyocardial biopsy. Although polymerase chain reaction–detectable virus could be found in the lungs of most coronavirus disease-2019 (COVID-19)–infected subjects in our own autopsy registry, in only 2 cases was the virus detected in the heart. It should be appreciated that myocardial inflammation alone by macrophages and T cells can be seen in noninfectious deaths and COVID-19 cases, but the extent of each is different, and in neither case do such findings represent clinically relevant myocarditis. Given its extremely low frequency and unclear therapeutic implications, the authors do not advocate use of endomyocardial biopsy to diagnose myocarditis in the setting of COVID-19., Central Illustration, Highlights • Whether myocarditis is a cause of myocardial injury in patients with COVID-19 is uncertain. • Myocarditis is uncommon in autopsy or EMB in cases of COVID-19. • Further work is needed to fully understand the cardiac effects of COVID-19 infection.
- Published
- 2020